本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

3.24
-0.1700-4.99%
盤後3.250.0069+0.21%19:59 EDT
成交量:1,188.13萬
成交額:3,877.06萬
市值:17.33億
市盈率:-3.17
高:3.37
開:3.37
低:3.22
收:3.41
52周最高:7.18
52周最低:2.77
股本:5.35億
流通股本:5.22億
量比:0.91
換手率:2.27%
股息:- -
股息率:- -
每股收益(TTM):-1.0219
每股收益(LYR):-1.4410
淨資產收益率:-56.58%
總資產收益率:-27.33%
市淨率:1.89
市盈率(LYR):-2.25

資料載入中...

2024/12/04

關聯方擬減持公告

Form 144 | RECURSION PHARMACEUTICALS, INC. 高管 Gibson Christopher 擬減持20000股,總價約14.32萬美元
2024/12/03

重要事件披露

Form 8-K - Current report
2024/11/27

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/26

重要事件披露

Form 8-K/A - Current report: [Amend]
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/20

重要事件披露

Form 8-K - Current report
2024/11/14

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/11/04

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities